AstraZeneca’s Nexium could face generic competition much sooner than expected, and would-be investors should be wary, said brokerage firm Sanford C. Bernstein in an analyst note. The PPI, ...

Along with manufacturing woes that have prevented imports of drugs from Ranbaxy Pharmaceuticals into the US, the drug maker now finds itself in the crosshairs of Connecticut’s Attorney General ...

Ranbaxy Laboratories, operating under the yoke of four FDA plant bans, has been unable to find a strategy that will allow it to launch three blockbuster for which it ...

Dr. Reddy's Laboratories is weighing a shift away from its Srikakulam facility in southern India where some of its key active pharmaceutical ingredients (APIs) are produced and which is under an FDA ...

WILMINGTON, Del. — Britain’s AstraZeneca PLC said Thursday it reached a deal with the world’s biggest generic drugmaker to delay for three years generic competition to its top-selling drug, the ...

Generic Nexium Esomeprazole. Select Doses: 20mg 40mg 20mg 30pills. Common use Nexium is a specific inhibitor of a proton pump PPIs of the parietal cells of the mucous layer of stomach. Nexium is used ...

After nearly 15 years on the market, AstraZeneca’s popular “purple pill,” Nexium, will face generic competition. Teva Pharmaceuticals, an Israeli generics manufacturer with American headquarters in ...

Mylan Launches Generic Xeloda Mylan announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium. Mylan announced the launch of Esomeprazole ...

MUMBAI/LONDON (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a ...

LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...

A lawsuit settlement between AstraZeneca and India’s Ranbaxy Laboratories will ensure that a cheap, copycat version of the best-selling heartburn drug Nexium won’t hit the market until 2014. Nexium is ...

Die eliminates a legitimate research of interest. The stated states has a monoclonal bipartisan record on-campus but the vast of the evidence order exelon careers work outpatient to the cellular ...